Orchid Island Capital Announces January 2014 Monthly

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Orchid Island Capital Announces January 2014 Monthly Dividend and December 31, 2013 MBS Portfolio Characteristics
  • January 2014 Monthly Dividend of $0.18 Per Share
  • Estimated Book Value Per Share at December 31, 2013 of $13.40
  • MBS Portfolio Characteristics as of December 31, 2013

VERO BEACH, Fla., Jan. 9, 2014 (GLOBE NEWSWIRE) -- Orchid Island Capital, Inc. (the "Company") (NYSE MKT:ORC) announced that today the Board of Directors declared a monthly cash dividend for the month of January 2014. The dividend of $0.18 per share will be paid January 31, 2014, to holders of record on January 27, 2014, with an ex-dividend date of January 23, 2014.

The Company intends to make regular monthly cash distributions to its stockholders. In order to qualify as a real estate investment trust ("REIT") the Company must distribute annually to its stockholders an amount at least equal to 90% of its REIT taxable income, determined without regard to the deduction for dividends paid and excluding any net capital gain. The Company will be subject to income tax on taxable income that is not distributed and to an excise tax to the extent that certain percentages of its taxable income is not distributed by specified dates. The Company has not established a minimum distribution payment level and is not assured of its ability to make distributions to stockholders in the future.

Estimated December 31, 2013 Book Value Per Share

The Company's estimated book value per share as of December 31, 2013 was $13.40. Book value per share is regularly used as a valuation metric by various equity analysts that follow the Company and may be deemed a non-GAAP financial measure pursuant to Regulation G. The Company computes book value per share by dividing total stockholders' equity by the total number of shares outstanding of the Company's Common Stock. At December 31, 2013, the Company's preliminary estimated total stockholders' equity was approximately $44.8 million with 3,341,665 Common shares outstanding. These figures and the resulting estimated book value per share are preliminary, subject to change, and subject to audit by the Company's independent registered public accounting firm.

MBS Portfolio Characteristics

Details of the MBS portfolio as of December 31, 2013 are presented below. These figures are preliminary and subject to change. The information contained herein is an intra-quarter update created by the Company based upon information that the Company believes is accurate.

  • MBS Assets by Agency
  • Investment Company Act of 1940 Whole Pool Test Results
  • Repurchase agreement exposure by counterparty
  • MBS Risk Measures

About Orchid Island Capital, Inc.

Orchid Island Capital, Inc. is a specialty finance company that invests in Agency RMBS that are either traditional pass-through Agency RMBS or structured Agency RMBS. Orchid Island Capital, Inc. intends to elect to be taxed as a real estate investment trust for federal income tax purposes.

Forward Looking Statements

This press release contains forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. These forward looking statements are based upon Orchid Island Capital, Inc.'s present expectations, but these statements are not guaranteed to occur. Investors should not place undue reliance upon forward looking statements. For further discussion of the factors that could affect outcomes, please refer to the "Risk Factors" section of the Company's Form 10-K for the year ended December 31, 2012.

MBS Valuation Characteristics
(in thousands of $s)
        Percentage Weighted Realized
  Current Fair Current of Average Dec 2013 CPR
Asset Category Face Value Price Portfolio Coupon (Reported in Jan)
As of December 31, 2013            
Adjustable Rate MBS  $ 4,935    $ 5,334    108.08  1.52% 3.92% 0.27%
10-1 Hybrid Rate MBS  76,952   76,118   98.92  21.67% 2.56% 2.63%
Hybrid Adjustable Rate MBS  76,952   76,118   98.92  21.67% 2.56% 2.63%
15 Year Fixed Rate MBS  21,817   22,284   102.14  6.34% 3.00% 1.29%
20 Year Fixed Rate MBS  30,743   31,400   102.14  8.94% 3.50% 1.78%
30 Year Fixed Rate MBS  183,537   191,839   104.52  54.63% 4.26% 3.91%
Total Fixed Rate MBS  236,097   245,523   103.99  69.91% 4.05% 3.39%
Total Pass-through MBS  317,984   326,975   102.83  93.10% 3.70% 3.16%
Interest-Only Securities  128,534   19,206   14.94  5.47% 4.39% 20.29%
Inverse Interest-Only Securities  37,678   5,042   13.38  1.43% 5.92% 12.94%
Structured MBS  166,212   24,248   14.59  6.90% 4.71% 18.62%
Total Mortgage Assets  $ 484,196    $ 351,223    --  100.00% 3.77% 8.47%
   
MBS Assets by Agency Investment Company Act of 1940 (Whole Pool) Test
(in thousands of $s) (in thousands of $s)
    Percentage     Percentage
  Fair of   Fair of
Asset Category Value Portfolio Asset Category Value Portfolio
As of December 31, 2013     As of December 31, 2013    
Fannie Mae  $ 211,063  60.1% Whole Pool Assets $ 281,088  80.0%
Freddie Mac  121,842  34.7% Non Whole Pool Assets  70,135  20.0%
Ginnie Mae  18,318  5.2% Total Mortgage Assets $ 351,223  100.0%
Total Mortgage Assets $ 351,223  100.0%      
 
Repurchase Agreement Exposure By Counterparty
(in thousands of $s)
      Weighted  
    % of Average  
  Total Total Maturity Longest
As of December 31, 2013 Borrowings Debt in Days Maturity
Citigroup Global Markets Inc $ 98,840  31.0% 11  1/15/2014
South Street Securities, LLC 49,411  15.5% 13  1/23/2014
Suntrust Robinson Humphrey, Inc 47,010  14.8% 10  1/10/2014
Cantor Fitzgerald & Co 39,185  12.3% 22  1/24/2014
Mizuho Securities USA, Inc 26,727  8.4% 9  1/13/2014
Morgan Stanley & Co 20,073  6.3% 13  1/13/2014
CRT Capital Group, LLC 15,146  4.8% 18  1/24/2014
KGS-Alpha Capital Markets, L.P 11,894  3.7% 16  1/24/2014
Goldman, Sachs & Co 10,155  3.2% 70  3/11/2014
Total Borrowings $ 318,441  100.0% 15  3/11/2014
 
MBS Risk Measures
(in thousands of $s)
Mortgage Assets
    Weighted        
    Average Weighted Weighted Modeled Modeled
    Months Average Average Interest Interest
    To Next Lifetime Periodic Rate Rate
  Fair Coupon Reset Cap Cap Per Year Sensitivity Sensitivity
Asset Category Value (if applicable) (if applicable) (if applicable) (-50 BPS)* (+50 BPS)*
As of December 31, 2013            
Adjustable Rate MBS $ 5,334  4  10.13% 2.00%  $ 13    $ (22)
Hybrid Adjustable Rate MBS  76,118  108  7.56% 2.00%  2,157  (2,444)
Total Fixed Rate MBS  245,523  n/a n/a n/a  6,385  (7,646)
Total Pass-through MBS  326,975  n/a n/a n/a  8,555  (10,112)
Interest-Only Securities  19,206  n/a n/a n/a (2,950)  2,070 
Inverse Interest-Only Securities  5,042  2  6.08% n/a  183  (240)
Structured MBS  24,248  n/a n/a n/a (2,767)  1,830 
Total Mortgage Assets  $ 351,223   n/a n/a n/a  $ 5,788    $ (8,282)
Funding Hedges
          Modeled Modeled
          Interest Interest
      Average Hedge Rate Rate
      Notional Period Sensitivity Sensitivity
      Balance End Date (-50 BPS)* (+50 BPS)*
Eurodollar Futures Contracts - Short Positions      $ 257,353  Dec-2018  $ (4,816)  $ 5,469 
Grand Total         $ 972   $ (2,813)

* Modeled results from Citigroup Global Markets, Inc. Yield Book. Interest rate shocks assume instantaneous parallel shifts and horizon prices are calculated assuming constant LIBOR OAS. These results are for illustrative purposes only and actual results may differ materially.

Orchid Island Capital, Inc. Robert E. Cauley 3305 Flamingo Drive, Vero Beach, Florida 32963 Telephone: (772) 231-1400

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 184

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 135

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 177

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 14

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 12

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 84

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 98

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

What Your $1000 Investment in ASML Could Be Worth Now

Updated Category News Views 269

Exploring ASML Holding's Remarkable Growth ASML Holding (NASDAQ: ASML) has established itself as a leader in the semiconductor industry, offering substantial growth for investors. Over the past 15 years, the stock has consistently outperformed the market, delivering an impressive annualized return of 23.78%. This performance exceeds the overall market's growth by 11.35%,...

Continue Reading
Nvidia and Adobe Lead Stock Movement Trends This Week

Updated Category News Views 87

Significant Stock Movements in Today's Market Today's trading session has brought notable activity in the stock market, particularly among mega-cap and large-cap companies. With significant price fluctuations and market activity, investors are closely analyzing trends influenced by various factors, such as earnings reports and market sentiment. Mega-Cap Market Movers When...

Continue Reading
Charlotte's Web Unveils Innovative Quiet Sleep Mushroom Gummies

Updated Category News Views 184

Charlotte's Web Launches Quiet Sleep Mushroom Gummies A recent survey highlights that 43% of Americans struggle with sleep due to racing thoughts. To address this common issue, Charlotte's Web Holdings, Inc. introduces a natural remedy in the form of Quiet Sleep Mushroom Gummies. These gummies are melatonin-free and free from CBD, utilizing the calming properties of...

Continue Reading
Brown Brothers Harriman Expands Team with New Senior Wealth Planner

Updated Category News Views 258

Brown Brothers Harriman Enhances Wealth Planning Services Brown Brothers Harriman & Co. (BBH) has taken a significant step in strengthening its Chicago presence by welcoming Kristina White as a Senior Wealth Planner. With years of experience as a Managing Director and Partner at McDermott Will & Emery, Kristina brings a wealth of expertise in sophisticated wealth...

Continue Reading
Hospitality Sector Innovates to Overcome Market Challenges

Updated Category News Views 78

Hospitality Sector Innovates to Tackle Market Challenges In recent years, hospitality stocks have contended with major obstacles, including economic uncertainties and shifts in global markets. Despite these challenges, this industry has shown remarkable resilience, continually adapting and innovating to thrive amid adversity. As Wall Street watches for economic changes,...

Continue Reading